1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Journal Article (3369)
  2. Meeting Abstract (1544)
  3. Review (164)
  4. Conference Paper (128)
  5. Book Section (124)
  6. Editorial (107)
  7. Research Letter (27)
  8. Miscellaneous (14)
  9. Book Whole (11)
  10. Guidelines (9)
  11. Correspondence (5)
Groups
  1. Center for Molecular Imaging and Biotechnology (5502)
  2. GSK Faculty (5304)
  3. Sloan Kettering Institute Faculty (3443)
  4. Tow Center for Developmental Oncology (TCDO) (2540)
  5. Department of Medicine (2432)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1823)

More Groups

People
  1. Richard O'Reilly (662)
  2. David Scheinberg (445)
  3. Ross Levine (426)
  4. Nai-Kong Cheung (419)
  5. Hedvig Hricak (387)
  6. Joan Massague (351)

More People

Years
  1. 2025 (1)
  2. 2024 (148)
  3. 2023 (248)
  4. 2022 (307)
  5. 2021 (289)
  6. 2020 (328)

More Years

Publications
  1. Blood (629)
  2. Cancer Research (188)
  3. Journal of Clinical Oncology (168)
  4. Journal of Nuclear Medicine (139)
  5. Biology of Blood and Marrow Transplantation (101)
  6. Proceedings of the National Academy of Sciences of the United States of America (95)

More Publications

Publishers
  1. American Society of Hematology (659)
  2. Nature Publishing Group (525)
  3. Elsevier Inc. (454)
  4. American Association for Cancer Research (366)
  5. Cell Press (354)
  6. Springer (202)

More Publishers

Results (5502)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reconstitution of the human nuclear RNA exosome
    Journal Article

    Januszyk, K.; Weick, E. M.; Lima, C. D.
    Methods in Molecular Biology (2020)

    Fulltext@MSK | Save
  • Deep direct likelihood knockoffs
    Conference Paper

    Sudarshan, M.; Tansey, W.; Ranganath, R.
    Neural Information Processing Systems Foundation (2020)

    Fulltext@MSK | Save
  • Somatic mutations are shared between circulating endothelial cells (CEC) and CD34+ hematopoietic stem cells (HSC) in patients with primary myelofibrosis. Can PMF-initiating cells derive from a common HSC/EC precursor?
    Meeting Abstract

    Farina, M.; Bernardi, S.; Polverelli, N.; Zanaglio, C.; D'Adda, M.; Malagola, M.; Re, F.; Cattina, F.; Zollner, T.; Rossi, G.; more...
    Haematologica (2020)

    Fulltext@MSK | Save
  • Comment on “Screening of asymptomatic surgical patients for SARS-CoV-2: The Covid19 Subcommittee of the Operating Room Executive Committee”
    Journal Article

    Covid-19 Subcommittee of the Operating Room Executive Committee; Kamboj, M.; Pessin, M.; Barber, T.
    Annals of Surgery (2020)

    Fulltext@MSK | Save
  • Early data from a phase II trial investigating the combination of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (HL)
    Meeting Abstract

    Sermer, D. J.; Vardhana, S. A.; Ames, A.; Biggar, E.; Moskowitz, A. J.; Batlevi, C. L.; Caron, P.; Hamilton, A. M.; Moskowitz, C. H.; Matasar, M. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • KITE-439: A phase I study of HPV16 E7 T cell receptor-engineered T cells in patients with relapsed/refractory HPV16-positive cancers
    Meeting Abstract

    Kirtane, K.; Massarelli, E.; Hanna, G. J.; Klebanoff, C. A.; Blumenschein, G.; Bishop, M. R.; Lee, S.; Niu, J.; Adhikary, S.; Astrow, S. H.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase I and randomized phase II etctn study of KW-0761 (Mogamulizumab) and MK-3475 (Pembrolizumab) in relapsed and refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Joffe, E.; Vardhana, S. A.; Kumar, A.; Abedi, M.; Hoeg, R.; Sharon, E.; Younes, A.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • STK11 and KEAP1 co-mutation cooperatively promotes rapid tumor growth in lung adenocarcinoma
    Meeting Abstract

    Wohlhieter, C. A.; Richards, A. L.; Poirier, J. T.; Uddin, F.; Hulton, C.; De Stanchina, E.; Papagiannakopoulos, T.; Sen, T.; Rudin, C. M.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • A primary mouse model of AML as a new way to screen novel therapeutics and treatment combinations
    Meeting Abstract

    Johnson, M. L.; Elgamal, O. A.; Harrington, B.; Mustonen, A.; Lehman, A.; Bennett, C.; Dzwigalski, K. R.; Hill, K. L.; Phelps, M. A.; Truxall, J.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Renal tubule-targeted supportive care nanotherapy for cisplatin-induced acute kidney injury
    Meeting Abstract

    Heller, D. A.; Jaimes, E.; Williams, R.; Shah, J.
    Cancer Research (2020)

    Fulltext@MSK | Save